文献速递心脑血管急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

机械取栓与导管定向溶栓治疗肺栓塞的比较:系统评价与Meta分析

Comparing mechanical thrombectomy and catheter directed thrombolysis for pulmonary embolism: A systematic review and meta-analysis.
PubMed 文献 · Am J Emerg Med · 2025-06-25
一句话结论基于1项RCT和6项观察性研究的Meta分析显示,机械取栓与导管定向溶栓治疗肺栓塞的临床结局相当,机械取栓可能缩短住院时间,但证据有限需谨慎解读。

该系统评价与Meta分析纳入1项随机对照试验和6项观察性研究,共1369例肺栓塞患者(机械取栓659例,导管定向溶栓710例),比较机械取栓与导管定向溶栓的疗效与安全性。主要终点全因死亡率(RR=1.24,95%CI 0.47-3.30)、全因再入院(RR=0.84,95%CI 0.29-2.41)和肺栓塞相关再入院(RR=0.64,95%CI 0.13-3.23)均无显著差异。机械取栓与住院时间缩短相关(平均差-0.47天,95%CI -0.89至-0.05,p=0.03,I²=0%),但操作时间、透视时间和ICU住院时间无显著差异。作者认为现有证据主要来自观察性研究,两种方法临床结局相当,机械取栓可能缩短住院时间,但限于研究设计和异质性,结论需谨慎解读,需进一步高质量随机试验。

要点

  • 机械取栓与导管定向溶栓的全因死亡率无显著差异(RR=1.24,95%CI 0.47-3.30,p=0.66,I²=26%)。
  • 机械取栓与住院时间缩短相关(平均差-0.47天,95%CI -0.89至-0.05,p=0.03,I²=0%)。
  • 全因再入院(RR=0.84,95%CI 0.29-2.41)和肺栓塞相关再入院(RR=0.64,95%CI 0.13-3.23)无显著差异。
  • 操作时间(平均差21.48分钟,95%CI -5.20至48.15)、透视时间(平均差6.63分钟,95%CI -3.14至16.41)和ICU住院时间(平均差-6.45天,95%CI -20.25至7.36)无显著差异。
  • 证据主要来自观察性研究(1项RCT和6项观察性研究,共1369例),作者认为需进一步高质量随机试验以得出确定性结论。

适用人群与场景

  • 肺栓塞患者,来自随机对照试验和观察性研究,共1369例(机械取栓659例,导管定向溶栓710例)。

研究设计与关键结果

  • 系统评价与Meta分析纳入1项随机对照试验和6项观察性研究,共1369例肺栓塞患者(机械取栓659例,导管定向溶栓710例)。
  • 机械取栓与导管定向溶栓相比,住院时间平均差-0.47天(95%CI -0.89至-0.05,p=0.03,I²=0%)。
  • 全因死亡率无显著差异(RR=1.24,95%CI 0.47-3.30,p=0.66,I²=26%)。
  • 全因再入院无显著差异(RR=0.84,95%CI 0.29-2.41,p=0.75,I²=54%)。
  • 肺栓塞相关再入院无显著差异(RR=0.64,95%CI 0.13-3.23,p=0.59,I²=0%)。
  • 操作时间无显著差异(平均差21.48分钟,95%CI -5.20至48.15,p=0.11,I²=95%)。
  • 透视时间无显著差异(平均差6.63分钟,95%CI -3.14至16.41,p=0.18,I²=93%)。
  • ICU住院时间无显著差异(平均差-6.45天,95%CI -20.25至7.36,p=0.36,I²=100%)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入1项随机对照试验和6项观察性研究。
  • 作者指出局限性包括研究设计(主要来自观察性研究)和异质性,结论应谨慎解读,需进一步高质量随机试验。

对床旁实践的改变

  • 作者认为,现有证据主要来自观察性研究,机械取栓与导管定向溶栓在肺栓塞治疗中提供相当的临床结局,机械取栓可能缩短住院时间,但鉴于研究设计和异质性等局限,这些发现应谨慎解读。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Pulmonary embolism (PE) is a critical condition requiring prompt intervention. Mechanical thrombectomy (MT) and catheter-directed thrombolysis (CDT) are emerging catheter-based therapies, but their comparative effectiveness remains uncertain, particularly given the predominance of observational studies.

METHODS: We conducted a systematic review and meta-analysis of studies identified through PubMed, Embase, and Web of Science from inception to February 10, 2025. Both randomized controlled trials and observational studies were included. Random-effects models were used for all analyses to account for anticipated heterogeneity. Primary outcomes were all-cause mortality, all-cause readmission, and PE-related readmission. Secondary outcomes included hospital stay, procedural time, and safety events. Heterogeneity was assessed using the I2 statistic.

RESULTS: This meta-analysis included one randomized controlled trial (RCT) and six observational studies, comprising a total of 1369 patients (MT = 659, CDT = 710). MT was associated with a statistically significant reduction in hospital stay compared to CDT (Mean Difference = -0.47 days, 95 % CI: [-0.89, -0.05]; p = 0.03, I2 = 0 %). However, there were no significant differences between MT and CDT in terms of all-cause mortality (RR = 1.24, 95 % CI: [0.47, 3.30]; p = 0.66, I2 = 26 %), all-cause readmission (RR = 0.84, 95 % CI: [0.29, 2.41]; p = 0.75, I2 = 54 %), or PE-related readmission (RR = 0.64, 95 % CI: [0.13, 3.23]; p = 0.59, I2 = 0 %). Similarly, no significant differences were observed in procedural time (Mean Difference = 21.48 min, 95 % CI: [-5.20, 48.15]; p = 0.11, I2 = 95 %), fluoroscopy time (Mean Difference = 6.63 min, 95 % CI: [-3.14, 16.41]; p = 0.18, I2 = 93 %), or ICU stay (Mean Difference = -6.45 days, 95 % CI: [-20.25, 7.36]; p = 0.36, I2 = 100 %).

CONCLUSION: Current evidence, primarily from observational studies, suggests that MT and CDT offer comparable clinical outcomes in PE management, with MT potentially associated with a shorter hospital stay. However, given the limitations inherent to the available data, including study design and heterogeneity, these findings should be interpreted cautiously. Further high-quality randomized trials are needed to draw definitive conclusions.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Afridi A, Ali MA, Cheema U, et al. Comparing mechanical thrombectomy and catheter directed thrombolysis for pulmonary embolism: A systematic review and meta-analysis. Am J Emerg Med. 2025. PMID: 40602356. doi:10.1016/j.ajem.2025.06.041

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。